QT prolongation in the STREAM Stage 1 Trial

BACKGROUND : STREAM (Standardized Treatment Regimen of Anti-TB Drugs for Patients with MDR-TB) Stage 1 demonstrated non-inferior efficacy of a shortened regimen (the Short regimen) for rifampicinresistant TB (RR-TB) compared to the contemporaneous WHO-recommended regimen. This regimen included moxif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, G., Bern, H., Chiang, C-Y., Goodall, R. L., Nunn, A. J., Rusen, I. D., Meredith, S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Union 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982645/
https://www.ncbi.nlm.nih.gov/pubmed/35351238
http://dx.doi.org/10.5588/ijtld.21.0403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982645/
https://www.ncbi.nlm.nih.gov/pubmed/35351238
http://dx.doi.org/10.5588/ijtld.21.0403

Ejemplares similares